Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mobilization at the Level of Schools on the Behavioral Change in Favor of the Fight Against Malaria in Mbandjock

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04570241
Recruitment Status : Recruiting
First Posted : September 30, 2020
Last Update Posted : September 30, 2020
Sponsor:
Information provided by (Responsible Party):
Pr Wilfred Fon Mbacham, Cameroon Coalition Against Malaria (CCAM)

Brief Summary:
The main aim of this study is to determine the effect of awareness campaigns by school children targeting their communities on knowledge, attitudes, and practices in malaria control in the Mbandjock health district. A two-arm, open-label, randomized controlled clinical trial will be adopted with the Mbandjock Health District as the test district and Sa'a Health District as control Health District. This will last from January 2017 to December 2020. The Lot Quality Assurance Sampling (LQAS) method was used. The health area was selected in the ratio 2:1. A total of 209 pupils and 209 adults shall be enrolled from households located in Mbandjock. Similarly, 114 pupils and 114 adults will be recruited in Sa'a. In addition, 57 teachers shall be enrolled in the District of Mbandjock only. A total of 703 participants shall be enrolled during the study.

Condition or disease Intervention/treatment Phase
Malaria Behavioral: Malaria toolkit Not Applicable

Detailed Description:

General objective To determine the effect of awareness campaigns by school children targeting their communities on knowledge, attitudes and practices in malaria control in the Mbandjock health district.

Specific objectives

  • To describe the socio-demographic characteristics of households in the health districts of Mbandjock and Sa'a at the time of the survey;
  • To measure the change due the intervention on knowledge of malaria transmission, diagnosis, treatment and prevention in the health district of Mbandjock;
  • To measure the change due the intervention on attitudes towards malaria diagnosis, treatment and prevention in the Mbandjock health district;
  • To measure the change due the intervention on practices in the diagnosis, treatment and prevention of malaria in the Mbandjock health district.

Methodology Study design A two-arm, open label, randomized controlled clinical trial will be adopted with Mbandjock health district as the test district and Sa'a Health District a Control Health District.

Study site and study population The study population will be the entire population of the Mbandjock and Sa'a communities.

Sampling method The Lot Quality Assurance Sampling (LQAS) method was used. Since this method requires that the intervention zones be divided into supervision areas, the health areas of each district were considered as supervision areas. The health area was selected in the ratio 2:1. In the test district 11 health areas were used and 6 health district in the control district. 19 households were selected for each health area as required by the LQAS method.

Sample size A total of 209 pupils and 209 adults shall be enrolled from households in Mbandjock. Similarly, 114 pupils and 114 adults will be recruited in Sa'a. In addition, 57 teachers shall be enrolled in the District of Mbandjock only. A total of 703 participants shall be enrolled during the study.

Duration of study The study duration is three years. This will last from January 2017 to December 2020.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 703 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:

A 2-arm, open-label, randomized controlled clinical trial will be adopted with the Mbandjock health district as the test district and Sa'a Health District a Control Health District.

The Lot Quality Assurance Sampling (LQAS) method was used. Since this method requires that the intervention zones be divided into supervision areas, the health areas of each district were considered as supervision areas. The health area was selected in the ratio 2:1. In the test district 11 health areas were used and 6 health district in the control district. 19 households were selected for each health area as required by the LQAS method.

A total of 209 pupils and 209 adults shall be enrolled from households in Mbandjock. Similarly, 114 pupils and 114 adults will be recruited in Sa'a. In addition, 57 teachers shall be enrolled in the District of Mbandjock only. A total of 703 participants shall be enrolled during the study.

Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Evaluation of the Effect of Mobilization at School Level on Behaviour Change in Favor of Malaria Control in the Health District of Mbandjock in Cameroon
Actual Study Start Date : January 20, 2017
Estimated Primary Completion Date : December 31, 2020
Estimated Study Completion Date : December 31, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Malaria

Arm Intervention/treatment
Active Comparator: Group A-Malaria toolkit
School children shall be trained on key malaria messages with a malaria toolkit. From the training received, the pupils will carry out awareness-raising in communities with key messages learnt.
Behavioral: Malaria toolkit
Knowledge, attitude, and practice on malaria

No Intervention: Group B-No malaria toolkit

School children shall not be trained on key malaria messages with a malaria toolkit. Pupils will not carry out awareness-raising in communities with key messages.

.




Primary Outcome Measures :
  1. Number of school children to be trained with the malaria toolkit in order to educate adults on malaria control in different communities in the Mbandjock Health District [ Time Frame: 24 months ]
    The intervention group will include 209 children to be trained with a toolkit on malaria in order to educate 209 adults in their different communities



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   9 Years to 65 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Children should be of school-going age.
  • Children belong to an authorized school.
  • Adult belonging to a household.

Exclusion Criteria:

  • Children not going to school.
  • Children not belonging to an authorized school.
  • An adult that cannot be identified with any household.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04570241


Contacts
Layout table for location contacts
Contact: Wilfred Fon Mbacham, PhD (+237) 677579180 wfmbacham@yahoo.com
Contact: Rose Leke, PhD (+237) 699957329 roseleke@yahoo.com

Locations
Layout table for location information
Cameroon
Mbandjock Health District Recruiting
Yaoundé, Centre, Cameroon, +237
Contact: Fidelia Tarla, MSc    (+237) 677577706    fideliatarla@gmail.com   
Contact: Line Dongmo, MPH    (+237) 675420201    dongmoline@gmail.com   
Sponsors and Collaborators
Cameroon Coalition Against Malaria (CCAM)
Investigators
Layout table for investigator information
Study Director: Esther Talla, MD MC-CCAM
Layout table for additonal information
Responsible Party: Pr Wilfred Fon Mbacham, Principal Investigator, Cameroon Coalition Against Malaria (CCAM)
ClinicalTrials.gov Identifier: NCT04570241    
Other Study ID Numbers: MCCCAM/10/02/2016
First Posted: September 30, 2020    Key Record Dates
Last Update Posted: September 30, 2020
Last Verified: September 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: Data on knowledge, attitude, and practice of malaria will be shared with the scientific community and policy makers
Supporting Materials: Clinical Study Report (CSR)
Time Frame: December 2020 and for a period of at least 10 years
Access Criteria: Must be a researcher or policy marker

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Pr Wilfred Fon Mbacham, Cameroon Coalition Against Malaria (CCAM):
Malaria
Awareness
Knowledge
Attitudes
Practices
Additional relevant MeSH terms:
Layout table for MeSH terms
Malaria
Protozoan Infections
Parasitic Diseases
Infections
Vector Borne Diseases